Name: Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders: Future Research Needs Paper Number 20 (en Inglés)
Price: 90.56 PEN
Availability: InStock
Author: And Quality, Agency for Healthcare Resea ; Human Services, U. S. Department of Heal
ISBN: 9781484033142

portada Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders: Future Research Needs Paper Number 20 (en Inglés)

Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders: Future Research Needs Paper Number 20 (en Inglés)

Formato

Libro Físico

Autor

U. S. Department of Heal Human Services

Agency for Healthcare Resea And Quality

Editorial

Createspace

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

28.0 x 21.6 x 0.3 cm

Peso

0.17 kg.

ISBN13

9781484033142

Categorías

Investigación médica

Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders: Future Research Needs Paper Number 20 (en Inglés)

U. S. Department of Heal Human Services (Autor) · Agency for Healthcare Resea And Quality (Autor) · Createspace · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 22 días háb.

S/ 201,23S/ 90,56

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

S/ 90,56

Llega entre el 14 Jul y el 22 Jul a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders: Future Research Needs Paper Number 20 (en Inglés)"

This Future Research Needs (FRN) report is based on a draft Agency for Healthcare Research and Quality comparative effectiveness review titled Interventions for Adolescents and Young Adults with autism spectrum disorder. The purpose of the review was to synthesize recent research focused on interventions for adolescents and young adults between the ages of 13 and 30 with autism spectrum disorder (ASD; autistic disorder, Asperger's syndrome, pervasive developmental disorder-not otherwise specified). We addressed questions related to: the effectiveness of therapies targeting core symptoms of ASD (impairments in communication, social interaction, and behavior); common medical or mental health comorbidities, including associated symptoms such as irritability; the process of transitioning to adulthood; and family outcomes. The Key Questions (KQs) for the review include: KQ1: Among adolescents and young adults with ASD, what are the effects of available interventions on the core symptoms of ASD? KQ2: Among adolescents and young adults with ASD, what are the effects of available interventions on common medical and mental health comorbidities (e.g., epilepsy, sleep disorders, motor impairments, obesity, depression, anxiety, acute and episodic aggression, attention deficit hyperactivity disorder, etc.)? KQ3: Among adolescents and young adults with ASD, what are the effects of available interventions on functional behavior, attainment of goals toward independence, educational attainment, occupational/vocational attainment, life satisfaction, access to health and other services, legal outcomes, and social outcomes? KQ4: Among adolescents and young adults with ASD, what is the effectiveness of interventions designed to support the transitioning process, specifically to affect attainment of goals toward independence, educational attainment, occupational/vocational attainment, life satisfaction, access to health and other services, legal outcomes, and social outcomes? KQ5: Among adolescents and young adults with ASD, what harms are associated with available interventions? (Harms are defined by the Effective Health Care Program as all possible adverse consequences of an intervention, including adverse events.) KQ6: What are the effects of interventions on family outcomes?